Global Botulinum Toxin in Medical Cosmetology Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Botulinum Toxin in Medical Cosmetology Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Botulinum Toxin is a neurotoxic protein produced by the bacterium Clostridium botulinum and related species. It prevents the release of the neurotransmitter acetylcholine from axon endings at the neuromuscular junction and thus causes flaccid paralysis. Infection with the bacterium causes the disease botulism. The toxin also used commercially in medicine, cosmetics.
Botulinum Toxin in Medical Cosmetology report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Botulinum Toxin in Medical Cosmetology market is projected to reach US$ 11380 million in 2034, increasing from US$ 5946.9 million in 2022, with the CAGR of 8.2% during the period of 2024 to 2034. Demand from Medical and Cosmetic are the major drivers for the industry.
Global key players of botulinum toxin in medical cosmetology include Allergan, Ipsen, Medytox, LIBP, etc. Global top five manufacturers hold a share over 93%. In terms of product, 100u is the largest segment, with a share over 34% And in terms of application, the largest application is cosmetic, with a share over 51%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Botulinum Toxin in Medical Cosmetology market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Allergan
Ipsen
Medytox
LIBP
Merz Pharmaceuticals
US World Meds
Hugel
Daewoong
Segment by Type
50U
100U
Others
Medical
Cosmetic
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Botulinum Toxin in Medical Cosmetology market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Botulinum Toxin in Medical Cosmetology, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Botulinum Toxin in Medical Cosmetology industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Botulinum Toxin in Medical Cosmetology in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Botulinum Toxin in Medical Cosmetology introduction, etc. Botulinum Toxin in Medical Cosmetology Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Botulinum Toxin in Medical Cosmetology market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Botulinum Toxin in Medical Cosmetology report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Botulinum Toxin in Medical Cosmetology market is projected to reach US$ 11380 million in 2034, increasing from US$ 5946.9 million in 2022, with the CAGR of 8.2% during the period of 2024 to 2034. Demand from Medical and Cosmetic are the major drivers for the industry.
Global key players of botulinum toxin in medical cosmetology include Allergan, Ipsen, Medytox, LIBP, etc. Global top five manufacturers hold a share over 93%. In terms of product, 100u is the largest segment, with a share over 34% And in terms of application, the largest application is cosmetic, with a share over 51%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Botulinum Toxin in Medical Cosmetology market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Allergan
Ipsen
Medytox
LIBP
Merz Pharmaceuticals
US World Meds
Hugel
Daewoong
Segment by Type
50U
100U
Others
Segment by Application
Medical
Cosmetic
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Botulinum Toxin in Medical Cosmetology market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Botulinum Toxin in Medical Cosmetology, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Botulinum Toxin in Medical Cosmetology industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Botulinum Toxin in Medical Cosmetology in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Botulinum Toxin in Medical Cosmetology introduction, etc. Botulinum Toxin in Medical Cosmetology Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Botulinum Toxin in Medical Cosmetology market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices